Status:
COMPLETED
A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components
Lead Sponsor:
AstraZeneca
Collaborating Sponsors:
St. John's Research Institute
Conditions:
Primary Hypertension
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
This is a randomised, open-label; parallel group, multicentric study comparing the efficacy and safety of fixed-dose-combinations of Metoprolol XL plus Amlodipine with individual components of the com...
Eligibility Criteria
Inclusion
- Patients of hypertension (primary) , as judged by 2 BP measurements before randomisation
- Those who have given their written consent for the study.
Exclusion
- Patients of other forms of hypertension (other than primary)
- Those who have consistently BP \> /=180/120mmHg
- Patients with a prior history of chest pain, heart attacks, conduction defects and strokes.
- Patients of diabetes requiring insulin,asthma and kidney diseases.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
402 Patients enrolled
Trial Details
Trial ID
NCT00819104
Start Date
November 1 2008
End Date
August 1 2009
Last Update
September 9 2009
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Hyderabad, Andhra Pradesh, India
2
Research Site
Ahmedabad, Gujarat, India
3
Research Site
Bangalore, Karnataka, India
4
Research Site
Calicut, Kerala, India